<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03629574</url>
  </required_header>
  <id_info>
    <org_study_id>34365</org_study_id>
    <nct_id>NCT03629574</nct_id>
  </id_info>
  <brief_title>Mechanical Ventilation During Cardiopulmonary Bypass</brief_title>
  <acronym>VENICE</acronym>
  <official_title>Evaluation of a Protocol of Protective Mechanical Ventilation During Cardiopulmonary Bypass in Cardiosurgery for Congenital Heart Diseseas</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Ospedaliera di Padova</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Ospedaliera di Padova</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is about a protocol of protective mechanical ventilation during cardiopulmonary
      bypass used during cardiosurgery for the correction of congenital heart diseases, to evaluate
      what's the best for the lungs
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 20, 2018</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of the damage of the air-blood membrane in a ventilation protocol and a non ventilation protocol during cardiopulmonary bypass</measure>
    <time_frame>Baseline, and 6, 12, 24 and 48 hours after the surgery</time_frame>
    <description>It will be assed the plasma level of proteins which usually are absent in the plasma (surfactant protein A and B) that change as a damage of the air-blood membrane appears.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Congenital Heart Disease</condition>
  <condition>Mechanical Ventilation Complication</condition>
  <condition>Cardiopulmonary Bypass</condition>
  <arm_group>
    <arm_group_label>Ventilated Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will receive a protective mechanical ventilation during cardiopulmonary byass. No drugs will be administered.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Not-ventilated group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>This group will not receive any kind of mechanical ventilation during cardiopulmonary byass. The ventilator will be switched off.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ventilation during cardiopulmonary bypass</intervention_name>
    <description>Mechanical ventilation during cardiopulmonary bypass</description>
    <arm_group_label>Ventilated Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  congenital heart diseases

          -  younger than 5 years

          -  CPB longer than 30 minutes in hypotermia

          -  elective surgery

          -  stable clinical conditions

        Exclusion Criteria:

          -  genetic anomalies

          -  mechanical ventilation before the surgery

          -  kidney injuries

          -  hepatic failure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>5 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>AOPadova</name>
      <address>
        <city>Padova</city>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Costantino Gallo</last_name>
      <phone>049 8214439</phone>
      <email>ce.sperimentazione@aopd.veneto.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>June 19, 2018</study_first_submitted>
  <study_first_submitted_qc>August 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 14, 2018</study_first_posted>
  <last_update_submitted>August 12, 2018</last_update_submitted>
  <last_update_submitted_qc>August 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda Ospedaliera di Padova</investigator_affiliation>
    <investigator_full_name>Cristiana Carollo</investigator_full_name>
    <investigator_title>Medical Doctor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

